Dispersive liquid-liquid microextraction based on solidification of floating organic droplet followed by spectrofluorimetry for determination of carvedilol in human plasma

Bioanalysis

Volumn 5, Issue 4, 2013, Pages 437-448

  Zamani Kalajahi, Monireh ^a   Fazeli Bakhtiyari, Rana ^b   Amiri, Mandana ^c   Golmohammadi, Ali ^d   Afrasiabi, Abbas ^d   Khoubnasabjafari, Maryam ^e   Jouyban, Abolghasem ^f  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TABRIZ   (Iran)

^c PAYAME NOOR UNIVERSITY   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CAPTOPRIL; CARVEDILOL; CLOPIDOGREL; DIGOXIN; ENALAPRIL; FUROSEMIDE; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE; LOSARTAN; MEVINOLIN; OMEPRAZOLE; OXAZEPAM; PANTOPRAZOLE; SPIRONOLACTONE; VALSARTAN; WARFARIN;

ACCURACY; ANALYTICAL PARAMETERS; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CORRELATION COEFFICIENT; DISPERSIVE LIQUID LIQUIDE MICROEXTRACTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STABILITY; DRUG STRUCTURE; FREEZE THAWING; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID PHASE MICROEXTRACTION; NONHUMAN; PH; RAT; SPECTROFLUOROMETRY;

CARBAZOLES; HUMANS; LIMIT OF DETECTION; LIQUID PHASE MICROEXTRACTION; PROPANOLAMINES; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE;

EID: 84874027114     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.326     Document Type: Article

References (38)

1. Rathod R, Prasad LPC, Rani S, Nivsarkar M, Padh H. Estimation of carvedilol in human plasma by using HPLC-fluorescence detector and its application to pharmacokinetic study. J. Chromatog. B 857, 219-223 (2007). (Pubitemid 47454566)
2. Packer M, Fowler MB, Roecker EB et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 106, 2194-2199 (2002). (Pubitemid 35222212)
3. Sponer G, Bartsch W, Hooper RG. Drugs acting on multiple receptors: b-blockers with additional properties. Handb. Exp. Pharmacol. 93(1), 131-226 (1990).
4. Nolte K, Backfisch G, Neidlein R. In vitro absorption studies with carvedilol using a new model with porcine intestine called BM-RIMO (Boehringer-Mannheim Ring model). Arzneimittel-Forschung/Drug Res. 49, 745-749 (1999). (Pubitemid 29448513)
5. Frishman WH. Carvedilol. New Engl. J. Med. 339, 1759-1765 (1998).
6. The World Anti-Doping Agency, The World Anti-Doping Code, The 2004 Prohibited list, International Standard. (2004).
7. Regenthal R, Krueger M, Koeppel C, Preiss R. Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs. J. Clin. Monit. Comput. 15, 529-544 (1999). (Pubitemid 30311655)
8. Morgan T. Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin. Pharmacokinet. 26, 335-346 (1994). (Pubitemid 24148199)
9. Strein K, Sponer G, Muller-Beckmann B, Bartsch W. Pharmacological profile of carvedilol, a compound with b-blocking and vasodilating properties. J. Cardiovas. Pharmacol. 10, S33-S41 (1987).
10. Sreevidya TV, Narayana B. Simple and facile methods for the determination of carvedilol in pharmaceuticals. Indian J. Chem. Technol.16, 74-789 (2009).
11. Pires CK, Marques KL, Santos JLM, Lapa RAS, Lima JLFC, Zagatto EAG. Chemiluminometric determination of carvedilol in a multi-pumping flow system. Talanta 68, 239-244 (2005). (Pubitemid 41606065)
12. Dogan B, Ozkan SA. Electrochemical behavior of carvedilol and its adsorptive stripping determination in dosage forms and biological fluids. Electroanalysis 17, 2074-2083 (2005). (Pubitemid 41766001)
13. Myung SW, Jo CH. Gas chromatograph-mass spectrometric method for the determination of carvedilol and its metabolites in human urine. J. Chromatog. B 822, 70-77 (2005).
14. Gannu R, Yamsani VV, Rao YM. New RP-HPLC method with UV-detection for the determination of carvedilol in human serum. J. Liq. Chromatogr. Rel. Technol. 30, 1677-1685 (2007). (Pubitemid 46641884)
15. Zarghi A, Foroutan SM, Shafaati A, Khoddam A. Quantification of carvedilol in human plasma by liquid chromatography using fluorescence detection: application in pharmacokinetic studies. J. Pharm. Biomed. Anal. 44, 250-253 (2007). (Pubitemid 46551580)
16. Ptáek P, Macek J, Klíma J. Liquid chromatographic determination of carvedilol in human plasma. J. Chromatogr. B 789, 405-410 (2003). (Pubitemid 36549209)
17. Hokama N, Hobara N, Kameya H, Ohshiro S, Sakanashi M. Rapid and simple micro-determination of carvedilol in rat plasma by high-performance liquid chromatography. J. Chromatogr. B 732, 233-238 (1999). (Pubitemid 29421765)
18. Lamprecht G, Stoschitzky K. Determination of carvedilol in human plasma by high-performance liquid chromatography applying on-line deproteination and column switching. Chromatographia 59, 551-554 (2004). (Pubitemid 38757146)
19. MacHida M, Watanabe M, Takechi S, Kakinoki S, Nomura A. Measurement of carvedilol in plasma by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. B 798, 187-191 (2003). (Pubitemid 37487717)
20. Do Carmo Borges NC, Mendes GD, De Oliveira Silva D, Rezende V, Barrientos-Astigarraga RE, De Nucci G. Quantification of carvedilol in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: application to bioequivalence study. J. Chromatogr. B 822, 253-262 (2005). (Pubitemid 40994059)
21. Gomes NA, Vaidya VV, Pudage AM, Joshi SS, Parekh SA, Tamhankar AV. Application of a sensitive, rapid and validated LC-MS-MS method for the determination of carvedilol in human plasma. Chromatographia 69, 19-25 (2009).
22. Talebpour Z, Taraji M, Adib N. Stir bar sorptive extraction and high performance liquid chromatographic determination of carvedilol in human serum using two different polymeric phases and an ionic liquid as desorption solvent. J. Chromatogr. A 1236, 1-6 (2012).
23. Mazzarino M, De La Torre X, Mazzei F, Botrè F. Rapid screening of beta-adrenergic agents and related compounds in human urine for anti-doping purpose using capillary electrophoresis with dynamic coating. J. Sep. Sci. 32, 3562-3570 (2009).
24. Clohs L, McErlane KM. Development of a capillary electrophoresis assay for the determination of carvedilol enantiomers in serum using cyclodextrins. J. Pharm. Biomed. Anal. 24, 545-554 (2001). (Pubitemid 32119569)
25. Xu LX, Hui N, Ma LY, Wang HY. Study on fluorescence property of carvedilol and determination of carvedilol by fluorimetry. Spectrochim. Acta A 61, 855-859 (2005). (Pubitemid 40415218)
26. Madrakian T, Afkhami A, Mohammadnejad M. Simultaneous spectrofluorimetric determination of levodopa and propranolol in urine using feed-forward neural networks assisted by principal component analysis. Talanta 78, 1051-1055 (2009).
27. Silva LC, Trevisan MG, Poppi RJ, Sena MM. Direct determination of propranolol in urine by spectrofluorimetry with the aid of second order advantage. Anal. Chim. Acta 595, 282-288 (2007). (Pubitemid 46990288)
28. Milanovel C, Hutta M. Influence of various biological matrices (plasma, blood microdialysate) on chromatographic performance in the determination of b-blockers using an alkyl-diol silica precolumn for sample clean-up. J. Chromatogr. B 765, 167-177 (2001). (Pubitemid 33079058)
29. Rezaee M, Assadi Y, Milani Hosseini MR, Aghaee E, Ahmadi F, Berijani S. Determination of organic compounds in water using dispersive liquid-liquid microextraction. J. Chromatogr. A 1116, 1-9 (2006).
30. Zgoła-Grzekowiak Agnieszka A, Grzekowiak T. Dispersive liquid-liquid microextraction. Trends Anal. Chem. 30, 1382-1399 (2011).
31. Leong MI, Huang SD. Dispersive liquid-liquid microextraction method based on solidification of floating organic drop combined with gas chromatography with electron-capture or mass spectrometry detection. J. Chromatogr. A 1211, 8-12 (2008).
32. US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Center for Veterinary Medicine. Guidance for Industry Bioanalytical Method Validation. (2001).
33. Ganjali MR, Sobhi HR, Farahani H, Norouzi P, Dinarvand R, Kashtiaray A. Solid drop based liquid-phase microextraction. J. Chromatogr. A 1217, 2337-2341 (2010).
34. Stojanovic J, Vladimirov S, Marinkovic V, Velickovic D, Sibinovic P. Monitoring of the photochemical stability of carvedilol and its degradation products by the RP-HPLC method. J. Serb. Chem. Soc. 72, 37-44 (2007).
35. Gonçalves C, Alpendurada MF. Multiresidue method for the simultaneous determination of four groups of pesticides in ground and drinking waters, using solid-phase microextraction-gas chromatography with electron-capture and thermionic specific detection. J. Chromatogr. A 968, 177-190 (2002). (Pubitemid 34880007)
36. Surenda Bansal AD. Key elements of bioanalytical method validation for small molecules. AAPS J. 9, art No. 11 (2007).
37. Hermann M. HPLC Methods for Clinical Pharmaceutical Analysis. A User's Guide. Wiley-VCH, Weinheim, Germany (2012).
38. Jeong DW, Kim YH, Ji HY, Youn YS, Lee KC, Lee HS. Analysis of carvedilol in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry. J. Pharm. Biomed. Anal. 44, 547-552 (2007). (Pubitemid 46887635)